Cook, Inc. Coated Stent IDE Clearance Follows J&J/Cordis By One Month
This article was originally published in The Gray Sheet
Executive Summary
Cook, Inc.' s March 2 investigational device exemption clearance appears to have cut Johnson & Johnson's six to eight-month lead in bringing a drug-eluting stent to the U.S. market by at least half.